Patients Patient involvement in trial design: looking to the future COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face